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ABSTRACT
East Africa has one of the world’s fastest growing human populations—many of whom are dependent on livestock—as
well as some of the world’s largest wildlife populations. Humans, livestock, and wildlife often interact closely, intimately
linking human, animal, and environmental health. The concept of One Health captures this interconnectedness, including
the social structures and beliefs driving interactions between species and their environments. East African policymakers
and researchers are recognising and encouraging One Health research, with both groups increasingly playing a leading
role in this subject area. One Health research requires interaction between scientists from different disciplines, such as the
biological and social sciences and human and veterinary medicine. Different disciplines draw on norms, methodologies,
and terminologies that have evolved within their respective institutions and that may be distinct from or in conflict with one
another. These differences impact interdisciplinary research, both around theoretical and methodological approaches and
during project operationalisation. We present experiential knowledge gained from numerous ongoing projects in northern
Tanzania, including those dealing with bacterial zoonoses associated with febrile illness, foodborne disease, and anthrax.
We use the examples to illustrate differences between and within social and biological sciences and between industrial-
ised and traditional societies, for example, with regard to consenting procedures or the ethical treatment of animals. We
describe challenges encountered in ethical approval processes, consenting procedures, and field and laboratory logistics
and offer suggestions for improvement. While considerable investment of time in sensitisation, communication, and col-
laboration is needed to overcome interdisciplinary challenges inherent in One Health research, this can yield great
rewards in paving the way for successful implementation of One Health projects. Furthermore, continued investment in
African institutions and scientists will strengthen the role of East Africa as a world leader in One Health research.
INTRODUCTION
Eastern Africa has one of the highest predictedhuman population growth rates on the planet.1 It is
also home to some of the world’s largest wildlife popula-
tions, many of which live in close proximity to people
and livestock—directly linking people’s lives to the
health of livestock and the natural environment. The
interdependence of human, animal, and environmental
health—termedOneHealth2—creates both unique chal-
lenges and opportunities that could make East Africa a
world leader in the development of One Health research
and policy. The instinctive understanding of these inter-
dependencies, together with the maturing of health
research institutions and the establishment of One
Health research consortia inAfrica, provides an opportu-
nity for African scientists and institutions to lead the
global One Health agenda. Moreover, in East Africa,
One Health is also embraced by policymakers in some
countries, such as Tanzania and Kenya, to the extent
that they have established One Health departments
within their governments.3,4 These intersectoral units
set out not only to establish the interdisciplinary collab-
orations required for effective responses to emerging
zoonotic diseases, but also to recognise the challenges of
endemic zoonoses that continue to threaten human and
animal health.5 The growing awareness of endemic zoo-
noses as an important cause of common human disease
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syndromes, including fever,6–10 emphasises the relevance of
One Health as a daily health concern, beyond outbreaks of
“newsworthy” diseases such as Ebola, SARS, or highly path-
ogenic avian influenza (HPAI).
One Health research requires the collaboration of multi-
ple disciplines, including medical, veterinary, and biological
scientists alongside quantitative and qualitative social scien-
tists. As dramatic advancesweremade inmedical science and
the practice of human medicine in industrialised societies in
the 20th century, medicine, veterinary medicine, and social
sciences developed as largely separate entities, with separate
professional and scientific organisations. The growth of One
Health publications has surpassed that of life science publica-
tions overall, suggesting an increased uptake of interdiscipli-
nary approaches.11 Even so, publication silos and differences
in attitudes and best practices between and within biological
and social sciences continue to exist. These differences impact
interdisciplinary research, not just in terms of theoretical and
methodological approaches, but also with regard to the oper-
ationalisation of the projects through, for example, ethical
approvals, consent procedures, laboratory requirements,
and authorship of publications.
In this contribution, we share our experiential knowl-
edge gained from implementation and management of One
Health research programs in northern Tanzania, concentrat-
ing on bacterial zoonoses research—conducted by the
University of Glasgow, in collaboration with a wide range
of Tanzanian and international partners—and on the devel-
opment of bespoke zoonoses laboratory space at the
Kilimanjaro Clinical Research Institute (KCRI) in Moshi.
We begin with a discussion of ethical approval, which needs
to be in place before field or laboratory work commences,
and present some of the issues that may arise when working
across social and biological disciplines. We continue with a
description of some of the challenges in developing field-
based and laboratory capacity for One Health research,
where differences between human and animal health proc-
esses and policies come to the fore. Finally, we use case
examples from current research projects to demonstrate
research opportunities when such challenges are overcome
and One Health research can be effectively implemented.
ONE HEALTH RESEARCH ETHICS
Regardless what type of human or animal research is con-
ducted, the safety and protection of research participants
should be paramount, and ethical committees and review
procedures have a key role in safeguarding them.12,13
Owing to its interdisciplinary, interinstitutional, and, fre-
quently, international nature, ethical review of One Health
projects can pose special challenges, an issue that is also rec-
ognised in relation to review of funding applications for One
Health research.14 Different disciplines draw on norms,
methodologies, and terminologies that have evolved and
become accepted within their respective institutions. As
ethics committees are usually embeddedwithin each of these
institutions, the review process for interdisciplinary research
can be problematic. An ethics committeewhosemembers are
familiar with biomedical research may struggle to assess
research that is based on social science and vice versa. For
example, in the initial review of one of our projects, focused
on understanding the dairy value chain in northern
Tanzania, members of a biomedical ethics committee were
unfamiliar with the use of standard social science research
terminology—such as “actor” and “purposive sampling”—
which caused an obstacle to approval. The reviewers also
expressed a strong preference for written over verbal con-
sent, as is standard in medical research. While written con-
sent is also common practice across the social sciences, it is
not always appropriate—such as within communities with
high illiteracy rates. When written consent cannot be given,
the discipline norm is to record verbal consent. Rigid ethical
regulations that insist on a written method of consent could
preclude data collection in situations where such procedures
would be challenging to apply.15 A consequence of this could
be that research on marginalised groups becomes more diffi-
cult or even impossible to carry out, which could lead to
unethical outcomes of an ethical review process.15 Another
layer of complexity is added by the fact that many One
Health projects involve multiple institutions, often in multi-
ple countries, and often with their own or even multiple
consenting procedures, for example human subjects vs. ani-
mal research. For some of our bacterial zoonoses projects,
ethical review was required by up to 7 committees across
4 countries. Questions about ethical jurisdiction can arise
when multiple international and local institutional ethics
committees involved in ethical review take different
positions.16
Human Subjects Research
Informed consent is the cornerstone of ethical scientific
research involving people, whether as research subjects or
as owners of animal research subjects. The informed-
consent process is comprised of 3 key tenets17: firstly, the
participant must be given full and transparent information
about the research and their rights in an easily understand-
able manner; secondly, the participant must comprehend
what is being asked of him or her; and lastly, the participant
must freely agree to take part in the research.
The convention for the first tenet—provision of
information—is to produce written documents, such as
information sheets and consent forms, for participants. In
our research, these typically cover the study objectives,
potential risks and benefits of participating, research organi-
sations and funding bodies, confidentiality, who has
reviewed the study, what will happen to the results, and the
researchers’ contact details. The forms also include state-
ments encouraging participants to ask questions and inform-
ing them that they can withdraw from the research at
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any time. In Tanzania, the adult literacy level is 68%,18 indi-
cating that reliance on written documentation to convey in-
formation would likely exclude a considerable proportion of
potential study participants. This problem is made worse
by the fact that One Health research frequently involves
groups—such as women, rural populations, smallholder
farmers, or informal traders—who may have literacy rates
below the national average. Presenting written information
to a person with a low level of literacy may cause embarrass-
ment, something an ethical researcher should strive to
prevent rather than to precipitate. In our experience,
even literate participants often felt intimidated rather than
reassured by our consent documents. For example, our
Tanzanian research assistants reported the high level of detail
on our information sheets—especially the details of multiple
researchpartnerswith formal institutional logos—sometimes
caused concern about hidden goals of the research. Potential
participants refused to believe that somuch paperwork could
be associated with something as straightforward as taking
part in an interview or survey. Onmultiple occasions, people
mistook us for members of a group rumoured to have
malicious intent, a problem other researchers also encoun-
tered.19 Additionally, some of the information provided on
the forms—such as contact information for UK-based
researchers—was not meaningful to participants and thus
risked “information overload” for literate and illiterate partic-
ipants alike. This often resulted in important messages, such
as the right to refuse or withdraw participation, being buried
in other information.Bhutta drewattention to the drawbacks
of written information documents, arguing that they served
largely to satisfy researchers’ concerns over the legality of
the informed consent process rather than the needs of the
study participants.17 Requestingwritten confirmation of par-
ticipants’ consent, such as a signature, may also pose difficul-
ties when working with individuals or groups with low
literacy. In theory, this issue could be solved by taking partic-
ipants’ thumb prints, but in a study of U.S.- and developing
country-based researchers, respondents considered oral con-
sent preferable to written consent, both for sharing informa-
tion and for documenting consent.20 Likewise, for a survey of
informal milk vendors in Kenya, participants chose to give
consent verbally (140 of 230, 61%) rather than by signature
(39%), and none provided thumbprints.21
Considering the second tenet—comprehension—we
found it difficult to assess the degree to which consent was
genuinely informed even after the agreed informed-consent
procedure had been dutifully followed. The consent process
tended to take place quickly because the research was taking
people away from other activities and because participants
often became visibly bored when full details were read out
slowly. Moreover, although we attempted to clearly explain
the research activities, the gap between the researchers’ lived
experiences and those of the participants was vast and cre-
ated communication challenges. Despite high rates of con-
sent, we were not always confident that participants had
genuinely understood the research goals, nor had they had
time to reflect on whether or not to take part in the study.
This is not a new problem in development research. The
standard consent process of a single meeting between inves-
tigator and volunteer may be insufficient for adequate com-
prehension of informed consent.22 Indeed, Sreenivasan
argues that full comprehension is rarely achieved in research
and should be considered an ethical aspiration rather than a
minimum standard,23 claiming that if full comprehension
was a necessary condition of valid consent then much scien-
tific endeavour would be impossible. To protect prospective
research participants, their level of understanding can be
assessed prior to consenting. Cooper and colleagues used
comprehension and engagement scores to test the effective-
ness of 3 communication tools—written documents, illustra-
tive photographs, and illustrative cartoons—when providing
study information to 22 Tanzanian livestock keepers prior
to consent.21 Cartoons were associated with significantly
higher engagement scores, highlighting the usefulness of al-
ternative means of information provision.
Finally, the third tenet—freely agreeing to consent—
posed several problems. It proved difficult in some circum-
stances to identify who should be providing consent.
Western ethical models place emphasis on the individual;
however, in many African and other low- and middle-
income country (LMIC) contexts, additional consent at the
family or community level may be necessary.20,23–25 In
northern Tanzania, we sought permission of ward officials
or community leaders, such as village chairs, prior to con-
ducting key informant interviews. This was not required by
our ethics committees but was recommended as standard
practice by researchers with experience working in the area.
However, even this level of contingency was not always
Photo 1. Development of bespoke cartoons in consulta-
tion with Tanzanian end-users to create culturally appro-
priate communication tools for One Health research.
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sufficient. For one interview we visited a 19-year old infor-
mal milk trader at his family’s home. We were accompanied
by the village chair who had arranged the interview with the
trader’s prior agreement. Halfway through the interview we
were interrupted by the trader’s angry father, irate that we
were holding an interview on his compound without his
express consent. The village chair’s presence made no differ-
ence andwe had clearly violated a social or familial hierarch-
ical norm. Such situations have the potential to compromise
the safety andwellbeing of both researchers and participants,
thus breaching a fundamental bioethics principle to do no
harm.
A further difficulty with the third tenet is ensuring
that consent is truly voluntary. Power relations can have
coercive effects on consent. The presence of an outsider,
the endorsement by a community leader, or the gender
of a participant could all serve to socially or politically
pressure participants who feel they ought to participate.
The social desire to please others—whether conscious or
subconscious—is particularly strong if those others are per-
ceived as having power or control.26 In some instances,
women refused to be interviewed if their husbands were not
home to consent, although in some cases this may have been
a strategy for tacit refusal.27 Financial incentives can also be
coercive. We attempted to avoid this by not offering any
remuneration other than the reimbursement of travel
expenses. Although we made an exception when reimburs-
ing local officials for the time and costs of arranging research
activities, as is the local norm for recruiting these community
gatekeepers, this practice could have been construed as rein-
forcing power imbalances that discriminate against the poor
by unintentionally implying a poorer person’s time has less
value than the time of those privileged with education,
wealth, and social status.
Animal Research
Use of animals in research comes with its own ethical chal-
lenges, especially where multiple international partners are
involved. Animal research performed by researchers at
the University of Glasgow is governed by the Animals
(Scientific Procedures) Act 1986, implemented under
European Union (EU) Directive 2010/63/EU, which sets out
measures for the protection of animals used for scientific pur-
poses.28 Research funded by United Kingdom (UK) funders
or conducted by UK universities is required to comply with
this Act. However, while the UK Home Office provides
detailed guidance on implementation of the Act within the
UK, it does not take into consideration implementing work
overseas.28 The EU directive—largely developed with
housed laboratory animals in mind—does not necessarily
make adequate provision for research on other animals or
in other settings.29 These limitations make it difficult for
researchers and local animal welfare ethical review bodies
(AWERB) in the UK to interpret the guidance in
international contexts. Few African institutions have
AWERBS or institutional animal care and use committees
(IACUCS) to review animal research within One Health pro-
posals. Instead, issues relating to animal use in African coun-
tries are routinely addressed by AWERBs or IACUCs of
partner institutions inWestern countries. As a result, the pol-
icies and practices largely reflect the values and concerns of
societies in those countries,30 which may not necessarily be
the same as those in African or other non-Western societies.
While reviews of animal care and use in LMICs often empha-
sise the need for standards tomeet those evolving inWestern
countries,31 in this commentary we question whether and
why decisions made in Western countries are given prece-
dence as they may, in some cases, be inappropriate and ethi-
cally unacceptable to non-Western societies in Africa and
elsewhere.
Most studies on attitudes toward animal research have
been carried out across a narrow range of high-income coun-
tries in Europe and North America,32,33 while little research
has been conducted on the attitudes of people in lower-
income and agricultural-based societies, especially in the
LMICs. Furthermore, such studies tend to focus on a limited
number of animal species including non-human primates;
companion animals, such as dogs and cats; and laboratory
animals used in biomedical research, such as mice and rats.
Little attention has been given to species involved in One
Health research such as livestock and wildlife. Contact with
animals is likely to foster emotional attachment and empathy
towards the species involved and affects attitudes towards
animal use in research.34,35 In Western societies, most
human–animal contact involves companion animals or
equids and the emotional attachment formedwith those ani-
mals is reflected in the higher level of scrutiny given to the
use of these species in research.28 In those societies people
have little direct contact with livestock species, which tends
to preclude them from becoming objects of people’s positive
affections—resulting in attitudes dominated by the utilitar-
ian view of livestock as a source of products.36 In contrast,
in rural and peri-urban communities in African countries,
which comprise a large proportion of the population, people
live in close contact with livestock. In Maasai pastoral soci-
eties, where we conduct research on bacterial zoonoses,
many aspects of spirituality and mythology focus on the im-
portance of cattle, which are seen as manifestations of the
god, Ngai.37 Additionally, livestock and pastoral livelihoods
are crucial to Maasai identity as well as economic, social,
and cultural capital.38 Because the Maasai and other live-
stock-keeping societies often have complex spiritual and
practical relationships with livestock, a strong case can be
made for greater understanding of these relationships when
making decisions on animal use in research. For example,
during recent field trials to evaluate the efficacy of a new vac-
cine against malignant catarrhal fever (MCF) in Tanzania,39
residents of the Maasai communities—where the trials were
being conducted—expressed considerable misgivings about
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exposing cattle to the risk of a potentially fatal disease
through contact with wildebeest, even though the cattle in
question had been purchased from outside the community
specifically for the trial and were unknown to the commu-
nity. Although the Tanzania study protocol followed UK trial
guidelines40 and was compliant with the UK Animals
(Scientific Procedures) Act 1986 for euthanasia of animals
with severe clinical disease, euthanasia of healthy animals
that posed no disease risk to people or other animals was
not carried out at the end of the trial. Euthanasia was consid-
ered socially unacceptable in the Maasai communities and
the unnecessary loss of valued animals was likely to have
caused considerable concern among community members.
Even in Western societies, the harms and benefits of culling
of healthy animals are being re-evaluated, particularly in the
context of One Health, where not just human health but also
animal and environmental health are given consideration.2
Incorporating the Plurality of Ethical Perspectives
One Health research is challenging because it brings many
ethical considerations simultaneously to the fore: it is inter-
disciplinary and often international, endemic zoonoses dis-
proportionately impact poor and vulnerable populations
living in LMICs, and zoonoses research inherently covers
both animals and humans. The plurality of processes—with
different standards and procedures across committees
assessing medical, veterinary or social science research at
different organisations in multiple countries—often cause
considerable delays to projects due to the varied and
sometimes contradictory demands of the different ethical
bodies. The multiplicity of standards and ethical procedures
and practices is neither suitable nor adequate for this com-
plex area of research, and innovative solutions are urgently
required. Although there are legal constraints on modifica-
tions of ethics processes, we would like to suggest that the
balance between disciplines and between legal and ethical
aspects of the process may need to be reconsidered. More
specifically, our first suggestion is that One Health applica-
tions should be reviewed by a single ethical review commit-
tee, rather than separate committees for each discipline.
Such committees should be interdisciplinary—including
experts in human medicine, animal health, and social
sciences. Those committees would become familiar with
the language, culture, and standards of the different
disciplines—and consider all aspects of an interdisciplinary
One Health proposal in a single assessment. While there is
international agreement on the need for ethical conduct,
consent procedures, and oversight in human subjects
research, uniform implementation of Western guidelines
for ethical conduct may create conflict between the “spirit”
and “letter”—the underlying principles and technical
implementation—of such guidelines in other countries or
cultures.12,13,41 Our second suggestion, therefore, is that eth-
ical approvals from the country where the research is to be
conducted should be considered as possible basis for ethical
approval by the country where the funding originates. In
our example, this could mean that the University of
Glasgow would consider waiving the need for ethical ap-
proval if such approval were already granted by KCRI
and the National Institute for Medical Research (NIMR),
as the relevant local and national institutions, respectively,
in Tanzania. This would prevent “ethical colonialism”,
whereby ethical standards from one country are imposed
on another country without considering the cultural
appropriateness of the ethical requirements. Already, waiv-
ers for ethical review may be granted by institutions within
a single country—for example, across different universities
in New Zealand—and such an approach could be adopted
more widely, albeit with consideration of applicable legal
constraints. Finally, this system would also require develop-
ment of appropriately trained interdisciplinary ethics com-
mittees in LMICs. The development of an ethical and
compliance infrastructure should be included in capacity-
building initiatives, which, more often than not, focus on
physical spaces and equipment or on technical and scientific
skills, rather than on institutional, administrative, or ethical-
research infrastructure.
ONE HEALTH RESEARCH LOGISTICS
A major aim of zoonoses research is to generate data that
informs understanding of the linkages between human and
animal infection. To obtain insights into transmission proc-
esses between species and populations, epidemiological stud-
ies need to capture data on human and animal populations
and their connectivity. This requires the design and delivery
of multiple linked epidemiological studies and careful con-
sideration of the aims and intended outputs from each com-
ponent part. Because of the differences in the structure and
distribution of species and populations, the sampling units
or strategies appropriate for one species or population may
not apply to others, especially when contemporaneous col-
lection of samples or data from multiple species is needed.
For example, while hospital- or school-based approaches
may be the most efficient and cost-effective way to obtain
samples from human populations, comparable sampling
strategies for animal species are more difficult to find.
Where they do exist, such as through veterinary surveillance
or sampling at livestock markets or slaughterhouses, human
behavioural factors linked to disease reporting or to the sale
of particular livestock may make them poorly representative
of the true disease situation in animals.42,43 Household-based
sampling strategies where data are gathered from individuals
of multiple species present at the same place and time pro-
vide a way to gather fine-scale data from linked populations,
but these efforts are resource and time intensive, and defin-
ing a household may be a challenge in its own right.44
Careful evaluation of the nature of the linkages between
populations, the scales at which they are observed and
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sampled, and the trade-offs between optimal study design
and feasibility is crucial. The increasing availability of online
databases with molecular typing or sequencing data for
pathogens may provide a false sense of comparability across
studies, as the standardised format of such datamasks under-
lying differences in epidemiological origins and reporting
zeal.45 This may contribute to erroneous interpretations
regarding host-adaptation of pathogens or transmission
potential between host species,46 thus emphasising the need
for epidemiologically appropriate study designs in One
Health research.
Gaining access to appropriate laboratory space for proc-
essing of samples from people and animals can be difficult
due to differences in regulation, location, and operation of
human and animal diagnostic laboratories. For example,
quality assurance/quality control check lists, such as those
used by the U.S. National Institutes of Health Division of
AIDS, may include questions on the presence of animal sam-
ples in the laboratory, with the implication that animal sam-
ples pose an inherent biohazard that could affect human
infectious disease research. This is at odds with the fact that
the level of containment needs to reflect the hazard level of
the pathogen rather than the host species. For example,
Bacillus anthracis is a Hazard Group 3 organism regardless of
its origin. For some infections, such as HPAI, where false pos-
itive results could trigger a pandemic influenza alert, interna-
tional guidelines explicitly state that human and animal
samples should not be processed in the same laboratory.47
Some would argue that the hazard of cross-reactivity with
unrecognised diagnostic targets in samples of animal
origin could lead to false-positive results and that prudence
dictates separation of laboratories at all times. A counter
argument would be that such cross-reactivity can also
occur within human samples, meaning that separation of
laboratories does not fully resolve this issue.48 Cross-
contamination or cross-reactivity, while highly undesirable,
would be less impactful for endemic than epidemic infec-
tions. Implementation of good working practices supported
by standard operating procedures, risk assessments, and
staff-induction protocols should be put in place to minimise
cross-contamination risks in microbiological and molecular
laboratories, irrespective of the origin of samples. In our ex-
perience, sensitisation and training about zoonotic disease
research was key to overcoming initial resistance, building
consensus, and gaining acceptance of work on projects
involving human and animal samples for laboratory accredi-
tation bodies and staff alike.
An unintended consequence of the separation of labora-
tories and staff processing human and animal samples is lack
of communication. For example, our research team was
involved in anthrax diagnostics on animal-derived
material and was not aware of the availability of mole-
cular diagnostics for anthrax in human samples in an adja-
cent laboratory until a discussion about diagnostics was
sparked by the occurrence of human anthrax in northern
Tanzania.49 Such issues could be resolved by regular com-
munication between staff, staff training and cross-training,
and the collocation of human and veterinary diagnostic
facilities and experts. To allow for the processing of
animal-derived material from our One Health projects in
northern Tanzania, a physically separate containment level-
2 laboratory was set up within the suite of KCRI laboratories.
In this space, serum, milk, vaginal or cloacal swabs, faeces,
lymph nodes, kidneys, and meat can be safely processed
without the fear of compromising other studies performed
at this site. Establishment of this bespoke zoonoses labora-
tory at KCRI required considerable investment in time, fund-
ing, and relationship building as well as a combination of
general infrastructure-focused or capacity-building grants
and project-specific research grants; its future is dependent
on continued income generation. A major benefit of estab-
lishing the zoonoses laboratory is that we can now collect
and process both human and animal samples without the
need to routinely ship material to other laboratories. This
leads to more efficient generation of results; improved dis-
semination of result, for example, to participants, medical
or veterinary stakeholders, researchers, and policymakers;
enhanced response to findings; and a stronger sense of own-
ership in the source country. Further, the routine handling
and analysis of samples builds and sustains skills and capacity
Photo 2. Kilimanjaro Clinical Research Institute, Moshi,
Tanzania (top), and the welcome sign to the bespoke
Zoonoses lab set up within KCRI to enable One Health
research (bottom).
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within Tanzanian institutions, with potential for onward
training and capacity strengthening in other institutions.
For example, staff at the KCRI zoonoses laboratory now train
technicians and researchers from other institutions, includ-
ing government veterinary institutions, further enhancing
cross-sectoral engagement and capacity.
PROGRESS IN ONE HEALTH PROJECTS
To demonstrate the value of establishing a One Health
research platform, we describe some of our projects,
which span the spectrum from wildlife and livestock to
people and the values and perceptions that drive their
behaviour.
Zoonotic Causes of Febrile Illness
Febrile illness is a common cause of healthcare-seeking
behaviour and is often attributed to malaria. Research con-
ducted through the Kilimanjaro Christian Medical Centre-
Duke University collaboration, however, showed that
bloodstream infections and bacterial zoonoses caused more
than half of all febrile illnesses in paediatric and adult
patients.6 Bacterial zoonoses were 20 times more common
than malaria as a cause of illness in febrile admissions, yet
routine diagnostics for zoonoses are not available and many
healthcare providers identify low knowledge and testing
capacity as reasons for zoonoses under-diagnosis.50
Q fever and brucellosis, among other diseases, were com-
monly identified in febrile patients andmay have a ruminant
livestock reservoir. Within the genus Coxiella, the causative
agent of Q fever, only a single species is known, C. burnetii,
but different subtypes have been associated with cattle or
small ruminants as primary sources for human infection.51,52
Within the genus Brucella, which causes brucellosis, multiple
species are recognised: Brucella abortus is primarily found
in cattle and B. melitensis in sheep and goats. This host–
association is not absolute, and new Brucella species as well
as the possibility of adaptation of known Brucella species to
new host species at the wildlife–livestock interface is increas-
ingly recognised.53 Thus, a range of questions arises:
Which animal species contribute most to human infection
and disease? Which pathways of transmission are most
important? What are the critical points that can be tar-
geted for interventions? How are health interventions
and treatments perceived, understood and valued by live-
stock keepers? How do or could livestock handling
practices, milk and meat supply chains, household prepa-
ration, and consumption practices, and livestock vaccina-
tion influence disease occurrence?
Serological tests cannot differentiate between infections
caused by B. abortus, B. melitensis, or other Brucella species.
Because different Brucella species have distinct transmission
dynamics and control options, it is important to determine
the identity of Brucella in patients with fevers and in potential
reservoir host species. Achieving this requires access to the
actual bacteria, which is difficult to obtain due to low levels
of bacteremia in patients, transient bacterial shedding by
infected animals, and constraints on culture of the organism.
Using serological data from field studies and sophisticated
modelling approaches, goats were implicated as the most
likely source of human infection in northern Tanzania.54
This study also used simulated data to show that even small
amounts of data on bacterial species identity—or comparable
subtyping—are sufficient to inform models aimed at quanti-
fying transmission between host species, thus justifying
Photo 3. Staff training in standardized methodology for
carcass swabbing to support slaughterhouse-based sur-
veillance of meat borne pathogens such as non-typhoi-
dal Salmonella and Campylobacter species. Moshi,
Tanzania.
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considerable investment in obtaining such data.54 Such
efforts are now in progress, using human and animal sam-
pling collection platforms set up in collaboration with
human and veterinary medical professionals, and working
with molecular bacteriologists in the zoonosis laboratory
to prize this valuable information out of drops of urine,
blood, and milk.
Foodborne Zoonoses
Zoonoses can be transmitted through the milk supply and
value chain as well as the meat supply and value chain. Live
animals and animals at slaughter carry numerous bacteria
that are harmless, or commensal, when they reside in the
animal gut but are potentially dangerous pathogens once
they find their way into people. This is particularly true for
non-typhoidal Salmonella (NTS) and Campylobacter, which
are—among other signs and symptoms—associated with
invasive and often fatal disease and growth shortfalls, respec-
tively.55,56 In Tanzania, Salmonella has been detected on car-
casses of pigs and in fresh goat meat,57,58 while Campylobacter
has been found in faeces or on carcasses of pigs, cattle, and
ducks.59,60 People may acquire zoonotic Campylobacter from
beef, particularly when meat preparation and processing is
not undertaken properly,61 but it remains to be determined
whether animals or food of animal origin contribute to the
burden of human invasive NTS disease.56,62 Meat for con-
sumption may become contaminated with faecal bacteria
from the slaughtered animal, or with human- or animal-
derived bacteria found in the environment of slaughter
locations, butcheries, and eateries, such as on chopping
blocks, butcher knives, or “nyama choma” (ready-to-eat
meat). Targeted interventions require an understanding
of the relative contribution of those potential sources of
contamination and infection. Through a combination of
supply- and value-chain analysis, mathematical model-
ling, and molecular epidemiology studies, we aim to iden-
tify the contributions of these different sources to human
infections. The detection of NTS and Campylobacter in
slaughter animals, carcasses, meat, and the environment
is a crucial component of this work and is conducted in
the zoonoses laboratory at KCRI.
Anthrax
Anthrax is not normally thought of as a foodborne zoonosis,
however, many outbreaks in sub-Saharan Africa and else-
where have been attributed to meat consumption. In 2016,
ProMed—a global electronic reporting system for outbreaks
of emerging infectious diseases and toxins—reported cases
or government warnings related to consumption of cattle
in,63 for example, Kenya, Niger, Nigeria, Tanzania, and
Zimbabwe. An outbreak in people in Zambia was linked to
wildlife through the consumption of hippopotamus meat.64
While many Western scientists, regulatory agencies, and
funding bodies think of anthrax as a biowarfare agent and
impose very strict controls on anthrax research, it is an
endemic disease in much of sub-Saharan Africa where it
affects wildlife, livestock, and people.65 The spores of the
causative bacterium, Bacillus anthracis, survive in the natural
environment. Moreover, environmental factors drive inter-
actions between wildlife, livestock, and humans, and
between hosts and the environment, all of which impact the
risk of disease.66,67 Communities generally know the risk of
eating carcasses from animals that died from anthrax, and
some have developed traditional methods to determine
whether or not a carcass is safe to eat. When faced with a
choice between a high likelihood of malnutrition and a small
chance of falling sick, consumption of carcass meat is often
considered a risk worth taking, sometimes resulting in fatal
outcomes. Similarly, the risk of exposure toMCF fromwilde-
beest may drive herders to take their cattle to alternative
grazing areas despite a known risk of anthrax (O. R. Aminu,
oral communication, November 2016). To gain a better
understanding of the relationships between anthrax in wild-
life, livestock, and people, we are workingwith communities
in Ngorongoro Conservation Area (NCA) to map their
knowledge of anthrax, its spatial distribution, and its direct
and indirect impact on livestock and people. To make possi-
ble confirmation of anthrax diagnoses,we provide training to
animal health workers in the NCA in safe sample collection
methods and the use of personal protective equipment.
Samples are shipped to KCRI for culture-free confirmation
of the presence of anthrax and for genetic typing. Use of
molecular tools will also enable us to identify newly
emerging Bacillus strains such as B. cereus Biovar anthracis,
which has been associated with anthrax-like disease in
wildlife and livestock in numerous countries in West and
Central Africa.68,69
Photo 4. Cutaneous anthrax in a resident of the
Ngorongoro Conservation Area where anthrax is an
endemic disease with seasonal peaks in wildlife, live-
stock, and human case numbers.
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OUTLOOK
While the importance of One Health research is becoming
increasingly recognised, it takes time and effort to break
down the barriers between disciplines and their ways of
working, and to build the interdisciplinary research teams,
culture, and infrastructure needed to address One Health
questions. Open Access publishing should reduce financial
barriers to access to publications from other “silos”, but bar-
riers in language and methodology will take longer to come
down. In addition, institutional attitudes to ethical review
may continue to bedominatedbyWestern legislationandpri-
orities, regardless of the country or culture where the
research is conducted. Our experience in Tanzania suggests
that when those barriers are overcome, the opportunities for
One Health research open up. The importance of One Health
research, and the potential for African countries to play a
leading role in this arena, is recognised and encouraged by
policymakers and by regional and international funding
bodies alike. The establishment of the East African Health
Research Journal provides an opportunity to disseminate and
advocate forOneHealth research and is testament to the con-
fidence this regionhas in its capabilities. To date,muchofOne
Health research—particularly in thesocial sciences—hasbeen
led or carried out by non-African scientists. A range of initia-
tives aim to address this imbalance. Examples at the time of
writing include the Zoonoses and Emerging Livestock
Systems–Associated Studentship (ZELS-AS) program funded
by Research Councils UK and the Department for Interna-
tional Development, with PhD studentships and supervision
shared between high-, low-, and middle-income countries;
the Leverhulme–Royal Society Africa Awards, which fund a
PhD studentship and postgraduate training courses for East
African scientists; the Program for Enhancing the Health and
Productivity of Livestock (PEHPL), funded by the Bill and
MelindaGates Foundation,which supports non-western and
western PhD students at the Nelson Mandela African
Institution of Science and Technology (NM-AIST) in Arusha,
Tanzania; and the Developing Excellence in Leadership,
Training and Science (DELTAS) Africa program, which sup-
ports the Africa-led development of world-class researchers
and scientific leaders inAfrica.Wehope that current andnew
generations of scientists will consider the East African Health
Research Journal as aplatform for their publications.
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